JP2005529082A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005529082A5 JP2005529082A5 JP2003575884A JP2003575884A JP2005529082A5 JP 2005529082 A5 JP2005529082 A5 JP 2005529082A5 JP 2003575884 A JP2003575884 A JP 2003575884A JP 2003575884 A JP2003575884 A JP 2003575884A JP 2005529082 A5 JP2005529082 A5 JP 2005529082A5
- Authority
- JP
- Japan
- Prior art keywords
- deoxo
- aza
- homoerythromycin
- methyl
- pseudopolymorph
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 claims 34
- 238000000034 method Methods 0.000 claims 22
- 239000000243 solution Substances 0.000 claims 15
- 239000003960 organic solvent Substances 0.000 claims 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 9
- 239000000203 mixture Substances 0.000 claims 6
- 239000013078 crystal Substances 0.000 claims 5
- 238000002425 crystallisation Methods 0.000 claims 4
- 230000008025 crystallization Effects 0.000 claims 4
- 239000000543 intermediate Substances 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 3
- HRKNNHYKWGYTEN-HOQMJRDDSA-N (2r,3s,4r,5r,8r,10r,11r,12s,13s,14r)-11-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,8,10,12,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)NC[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 HRKNNHYKWGYTEN-HOQMJRDDSA-N 0.000 claims 2
- -1 9 -Deoxo-9a-aza-9a-methyl-9a-homoerythromycin A anhydride Chemical class 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 claims 2
- 150000002576 ketones Chemical class 0.000 claims 2
- 239000002994 raw material Substances 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- 238000003786 synthesis reaction Methods 0.000 claims 2
- 230000002194 synthesizing effect Effects 0.000 claims 2
- 208000035143 Bacterial infection Diseases 0.000 claims 1
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 claims 1
- 229930006677 Erythromycin A Natural products 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 206010037075 Protozoal infections Diseases 0.000 claims 1
- 150000001242 acetic acid derivatives Chemical class 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 230000002378 acidificating effect Effects 0.000 claims 1
- 125000001931 aliphatic group Chemical group 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 150000001350 alkyl halides Chemical class 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 150000001491 aromatic compounds Chemical class 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 208000022362 bacterial infectious disease Diseases 0.000 claims 1
- 235000013877 carbamide Nutrition 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 238000001816 cooling Methods 0.000 claims 1
- 150000004683 dihydrates Chemical class 0.000 claims 1
- 150000002009 diols Chemical class 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000006185 dispersion Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000002651 drug therapy Methods 0.000 claims 1
- 229960003276 erythromycin Drugs 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 150000002170 ethers Chemical class 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 1
- 150000003951 lactams Chemical class 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000011707 mineral Substances 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 150000004682 monohydrates Chemical class 0.000 claims 1
- 230000003472 neutralizing effect Effects 0.000 claims 1
- 150000002825 nitriles Chemical class 0.000 claims 1
- 150000007524 organic acids Chemical class 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 238000009738 saturating Methods 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 239000007858 starting material Substances 0.000 claims 1
- 150000003457 sulfones Chemical class 0.000 claims 1
- 150000003462 sulfoxides Chemical class 0.000 claims 1
- 150000004072 triols Chemical class 0.000 claims 1
- 150000003672 ureas Chemical class 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HR20020231A HRP20020231A2 (en) | 2002-03-18 | 2002-03-18 | ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A |
| US39361202P | 2002-07-03 | 2002-07-03 | |
| US39470502P | 2002-07-08 | 2002-07-08 | |
| PCT/IB2003/000987 WO2003077830A2 (en) | 2002-03-18 | 2003-03-18 | 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005529082A JP2005529082A (ja) | 2005-09-29 |
| JP2005529082A5 true JP2005529082A5 (enExample) | 2006-04-06 |
Family
ID=28045976
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003575884A Abandoned JP2005529082A (ja) | 2002-03-18 | 2003-03-18 | ９−デオキソ−９ａ−アザ−９ａ−メチル−９ａ−ホモエリスロマイシンＡ等構造擬似多形 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7569549B2 (enExample) |
| EP (2) | EP1485393B1 (enExample) |
| JP (1) | JP2005529082A (enExample) |
| KR (1) | KR20050002872A (enExample) |
| CN (1) | CN1642966A (enExample) |
| AT (1) | ATE440104T1 (enExample) |
| AU (1) | AU2003215779A1 (enExample) |
| BG (1) | BG108874A (enExample) |
| BR (1) | BR0308644A (enExample) |
| CA (1) | CA2479211A1 (enExample) |
| DE (1) | DE60328872D1 (enExample) |
| EA (1) | EA200401217A1 (enExample) |
| ES (1) | ES2331733T3 (enExample) |
| HR (2) | HRP20020231A2 (enExample) |
| IL (1) | IL163836A0 (enExample) |
| IS (1) | IS7449A (enExample) |
| MX (1) | MXPA04009009A (enExample) |
| NO (1) | NO20044341L (enExample) |
| NZ (1) | NZ535477A (enExample) |
| PL (1) | PL372468A1 (enExample) |
| RS (1) | RS82504A (enExample) |
| TN (1) | TNSN04166A1 (enExample) |
| WO (1) | WO2003077830A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20020231A2 (en) | 2002-03-18 | 2003-12-31 | Pliva D D | ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A |
| HRP20020614A2 (en) | 2002-07-22 | 2004-06-30 | PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. | Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a |
| EP1878432A1 (en) * | 2003-07-24 | 2008-01-16 | Pliva - Research and Development Ltd. | Single dose fast dissolving azithromycin |
| DE602004019288D1 (de) * | 2003-07-24 | 2009-03-19 | Pliva Hrvatska D O O | Schnellösliches azithromycin in einzeldosisform |
| WO2005053652A1 (en) | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride |
| ATE399536T1 (de) * | 2003-12-04 | 2008-07-15 | Pfizer Prod Inc | Verfahren zur herstellung von pharmazeutischen multiteilchenförmigen produkten |
| US6984403B2 (en) * | 2003-12-04 | 2006-01-10 | Pfizer Inc. | Azithromycin dosage forms with reduced side effects |
| AU2004294818A1 (en) * | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Azithromycin multiparticulate dosage forms by liquid-based processes |
| EP1689368B1 (en) * | 2003-12-04 | 2016-09-28 | Bend Research, Inc | Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions |
| EP1691786A1 (en) | 2003-12-04 | 2006-08-23 | Pfizer Products Inc. | Multiparticulate compositions with improved stability |
| US20060116336A1 (en) * | 2004-03-17 | 2006-06-01 | American Pharmaceutical Partners, Inc. | Lyophilized azithromycin formulation |
| US7468428B2 (en) * | 2004-03-17 | 2008-12-23 | App Pharmaceuticals, Llc | Lyophilized azithromycin formulation |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| YU43006B (en) | 1981-03-06 | 1989-02-28 | Pliva Pharm & Chem Works | Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof |
| RU2066324C1 (ru) * | 1987-07-09 | 1996-09-10 | Пфайзер Инк. | Кристаллический дигидрат азитромицина и способ его получения |
| HRP20020231A2 (en) | 2002-03-18 | 2003-12-31 | Pliva D D | ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A |
| ATE154806T1 (de) | 1993-05-19 | 1997-07-15 | Pfizer | Zwischenprodukt für azithromycin |
| HRP940251B1 (en) | 1994-04-15 | 1998-12-31 | Stjepan Mutak | Process for the preparation of azithromycin dihydrochloride |
| ES2122905B1 (es) * | 1996-07-11 | 1999-11-16 | Astur Pharma Sa | Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato). |
| PT102130A (pt) | 1998-03-13 | 1999-09-30 | Hovione Sociedade Quimica S A | Processo de preparacao de dihidrato de azitromicina |
| TW546302B (en) * | 1998-05-08 | 2003-08-11 | Biochemie Sa | Improvements in macrolide production |
| CN1205338A (zh) | 1998-05-08 | 1999-01-20 | 刘万忠 | 阿奇霉素水溶性盐的合成新方法及其在医药上的用途 |
| CA2245398C (en) | 1998-08-21 | 2002-01-29 | Apotex Inc. | Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof |
| CN100339384C (zh) * | 1998-11-30 | 2007-09-26 | 特瓦制药工业有限公司 | 阿齐霉素的乙醇化物，制备方法以及医药组合物 |
| DE20023815U1 (de) * | 1999-06-29 | 2006-06-08 | Sandoz Ag | Azithromycin enthaltende Zusammensetzungen |
| ES2177373B1 (es) * | 1999-11-26 | 2003-11-01 | Astur Pharma Sa | Preparacion de azitromicina en su forma no cristalina |
| DE60133083D1 (de) | 2000-01-04 | 2008-04-17 | Teva Pharma | Verfahren zur herstellung von azithromycin-dihydrat |
| ES2162764B1 (es) * | 2000-05-17 | 2003-04-01 | Ercros Ind Sa | Forma polimorfica del dihidrato de azitromicina, y su procedimiento deobtencion. |
| CA2417353C (en) | 2000-07-25 | 2009-09-01 | Laboratorio Silanes,S.A. De C.V. | Single-step process for preparing 7,16-deoxy-2-aza-10-o-cladinosil-12-o-desosaminil-4,5-dihydroxi-6-ethyl-3,5,9,11,13,15-hexamethylbicycle (11.2.1)hexadeca-1(2)-en-8-one, and obtaining a new form of 9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin a |
| WO2002015842A2 (en) | 2000-08-23 | 2002-02-28 | Wockhardt Limited | Process for preparation of anhydrous azithromycin |
| HU229488B1 (hu) * | 2000-11-27 | 2014-01-28 | Sandoz Ag | Eljárás makrolid hidrátok elõállítására |
| KR100491183B1 (ko) | 2001-03-21 | 2005-05-25 | 한미약품 주식회사 | 아지트로마이신의 제조방법 및 이 방법에 사용되는9-데옥소-9에이-아자-9에이-호모에리트로마이신 에이의결정성 수화물 |
| KR100431431B1 (ko) | 2001-04-25 | 2004-05-14 | 한미약품 주식회사 | 아지트로마이신 수화물의 1,2-프로필렌글리콜 내포화합물,그의 제조방법 및 그의 약학적 조성물 |
| HRP20010301A2 (en) | 2001-04-27 | 2001-12-31 | Pliva D D | New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases |
| US6861413B2 (en) | 2001-05-22 | 2005-03-01 | Pfizer Inc. | Stable non-dihydrate azithromycin oral suspensions |
| GEP20084399B (en) | 2001-05-22 | 2008-06-10 | Pfizer Prod Inc | Crystal forms of azithromycin |
| AU2002353316A1 (en) | 2001-12-21 | 2003-07-09 | Pfizer Products Inc. | Methods for wet granulating azithromycin |
| WO2003053416A1 (en) | 2001-12-21 | 2003-07-03 | Pfizer Products Inc. | Directly compressible formulations of azithromycin |
| RU2283092C2 (ru) | 2002-02-01 | 2006-09-10 | Пфайзер Продактс Инк. | Сухие гранулированные композиции азитромицина |
| ITMI20021209A1 (it) | 2002-06-04 | 2003-12-04 | Chemi Spa | Processo di preparazione di azitromicina ad elevata purezza |
-
2002
- 2002-03-18 HR HR20020231A patent/HRP20020231A2/hr not_active Application Discontinuation
-
2003
- 2003-03-17 US US10/390,573 patent/US7569549B2/en not_active Expired - Lifetime
- 2003-03-18 BR BR0308644-5A patent/BR0308644A/pt not_active Application Discontinuation
- 2003-03-18 EP EP03744475A patent/EP1485393B1/en not_active Expired - Lifetime
- 2003-03-18 DE DE60328872T patent/DE60328872D1/de not_active Expired - Fee Related
- 2003-03-18 AT AT03744475T patent/ATE440104T1/de not_active IP Right Cessation
- 2003-03-18 IL IL16383603A patent/IL163836A0/xx unknown
- 2003-03-18 MX MXPA04009009A patent/MXPA04009009A/es not_active Application Discontinuation
- 2003-03-18 HR HR20040858A patent/HRP20040858A2/xx not_active Application Discontinuation
- 2003-03-18 CN CNA038063263A patent/CN1642966A/zh active Pending
- 2003-03-18 EA EA200401217A patent/EA200401217A1/ru unknown
- 2003-03-18 EP EP05023731A patent/EP1627883A1/en not_active Withdrawn
- 2003-03-18 RS YU82504A patent/RS82504A/sr unknown
- 2003-03-18 JP JP2003575884A patent/JP2005529082A/ja not_active Abandoned
- 2003-03-18 WO PCT/IB2003/000987 patent/WO2003077830A2/en not_active Ceased
- 2003-03-18 NZ NZ535477A patent/NZ535477A/en unknown
- 2003-03-18 PL PL03372468A patent/PL372468A1/xx unknown
- 2003-03-18 ES ES03744475T patent/ES2331733T3/es not_active Expired - Lifetime
- 2003-03-18 AU AU2003215779A patent/AU2003215779A1/en not_active Abandoned
- 2003-03-18 CA CA002479211A patent/CA2479211A1/en not_active Abandoned
- 2003-03-18 KR KR10-2004-7014757A patent/KR20050002872A/ko not_active Withdrawn
-
2004
- 2004-09-03 TN TNP2004000166A patent/TNSN04166A1/en unknown
- 2004-09-14 BG BG108874A patent/BG108874A/xx unknown
- 2004-09-16 IS IS7449A patent/IS7449A/is unknown
- 2004-10-13 NO NO20044341A patent/NO20044341L/no unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2126416C1 (ru) | Производные эритромицина, фармацевтическая композиция на их основе, способ их получения и промежуточные соединения | |
| JP3334980B2 (ja) | 新規なエリスロマイシン誘導体、それらの製造法及びそれらの薬剤としての用途 | |
| CN101506220B (zh) | 大环内酯合成方法 | |
| JP2005529082A5 (enExample) | ||
| EP0827965B1 (en) | Synthesis of 9-deoxo- 9a-aza 11,12-deoxy- 9a-methyl-9a-homoerythromycin A 11,12- hydrogenorthoborate dihydrate | |
| HUP0300418A2 (hu) | Eljárás klaritromicin (II) típusú kristálymódosulatainak az előállítására | |
| US5202434A (en) | 8a-aza-8a-homoerythromycin lactams | |
| EP2471795B1 (en) | Method for preparing prasugrel | |
| ZA200300472B (en) | Process for the preparation of highly pure crystalline (R,S)-cefuroxime axetil. | |
| JPS5853000B2 (ja) | 新規抗菌剤 | |
| EP0503949B1 (en) | Novel process for the preparation of 9-deoxo-9(z)-hydroxyiminoerythromycin A | |
| MXPA04009009A (es) | Pseudopolimorfos isoestructurales de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a. | |
| WO2008010231A2 (en) | A process for the purification of topiramate | |
| JP5188520B2 (ja) | 新規なエリスロマイシン誘導体、製造方法及び医薬としての利用 | |
| CA2062932A1 (en) | 9-deoxo-9(z)-hydroxyiminoerythromycin a and o-derivatives thereof | |
| CN102875622B (zh) | 大环内酯合成方法 | |
| EP0508725A1 (en) | Novel process for the preparation of 8a-aza-8a-homoerythromycin cyclic iminoethers | |
| EP0508726A1 (en) | Novel process for the preparation of 9-deoxo-8a-aza-8a-homoerythromycin a and its 8a-alkyl derivatives | |
| CA2064985A1 (en) | 8a-aza-8a-homoertyhromycin cyclic lactams | |
| EP2520578A1 (en) | Process for purification of cephalosporins | |
| US7410952B2 (en) | Derivatives of azithromycin | |
| WO2006035291A1 (en) | Crystalline forms of cefdinir potassium | |
| CN101830949A (zh) | 一种阿奇霉素衍生物、其中间体及其制备方法和应用 | |
| JP2012520305A (ja) | テトラサイクリンのニトロ化 | |
| CN114075110B (zh) | 一种截短侧耳素的改性方法及其在泰妙菌素制备中的应用 |